The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta

Title
The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta
Authors
Keywords
-
Journal
LANCET INFECTIOUS DISEASES
Volume 15, Issue 10, Pages 1119-1120
Publisher
Elsevier BV
Online
2015-07-17
DOI
10.1016/s1473-3099(15)00155-3

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started